New Drug Application for RiVive Over-the-Counter Naloxone Nasal Spray Accepted and Granted Priority Review by FDA
PITTSBURGH, Dec. 26, 2022. Harm Reduction Therapeutics (HRT), Inc., a 501(c)(3) nonprofit pharmaceutical company whose mission is to prevent opioid overdose deaths by making free or low-cost over-the-counter (OTC) naloxone nasal spray available to... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - December 26, 2022 Category: Pharmaceuticals Source Type: clinical trials
Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk
Conditions: Opioid-Related Disorders; Hepatitis C (HCV); Human Immunodeficiency Virus (HIV); Drug Overdose; Substance Abuse; Intravenous Drug Usage; Opiate Substitution Treatment; Sexually Transmitted Diseases Intervention: Behavioral: Harm reduction kiosk Sponsors: April M Young; National Institute on Drug Abuse (NIDA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 20, 2022 Category: Research Source Type: clinical trials
